DGXQuest Diagnostics
$231.15+28% 1Y
$231.15
$171.9552 weeks$247.58
The financials
Quest Diagnostics by the numbers
Quest Diagnostics (DGX) reported revenue of $3.04B in Q2 2026 (quarter ended Jun 30, 2026), up 10% from the same quarter a year earlier. That came with a gross margin of 34% and net income of $320M (11% of revenue). For the full year FY2025, revenue was $11.0B (+12% year on year) and net income $992M. Its largest segment in Q2 2026 was Diagnostic Information Services Business at $2.98B, 98% of the disclosed total, well ahead of All Other at 2.1%. The next results filing is expected around Oct 20, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $3.04B | $2.76B | +10% |
| Gross profit | $1.03B | $943M | +8.9% |
| Operating income | $459M | $438M | +4.8% |
| Net income | $320M | $282M | +13% |
| Diluted EPS | $2.84 | $2.47 | +15% |
| Operating | Revenue | Share |
|---|---|---|
| Diagnostic Information Services Business | $2.98B | 98% |
| All Other | $65M | 2.1% |
Business segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Jun 2026Total $3.04B (+5.1%)
Diagnostic Information Services Business grew +10% year on yearAll Other +4.8% year on year
Segment Latestquarter on quarteryear on year
- Diagnostic Information Services Business$2.98B$2.98Bquarter on quarter +5.2%year on year +10%+5.2%+10%
- All Other$65.0M$65.0Mquarter on quarter +3.2%year on year +4.8%+3.2%+4.8%
Diagnostics & Research
The closest names by size in the same industry